Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung
This study is currently recruiting participants.
Verified March 2012 by Axelar AB
Sponsor:
Axelar AB
Information provided by (Responsible Party):
Axelar AB
ClinicalTrials.gov Identifier:
NCT01561456
First received: March 5, 2012
Last updated: March 21, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | April 2013 |
| Estimated Primary Completion Date: | April 2013 (Final data collection date for primary outcome measure) |